18:42 , Dec 22, 2017 |  BC Week In Review  |  Financial News

Hadean closes €100M life sciences fund

Hadean Ventures said it closed life sciences fund Hadean Capital I on Dec. 18 at €100 million ($117.9 million). Hadean will invest €6-€8 million ($7.1-$9.4 million) in about 10-12 European start-ups, with an emphasis on...
18:56 , Dec 21, 2017 |  BC Extra  |  Financial News

Hadean closes €100M life sciences fund

Hadean Ventures said it closed life sciences fund Hadean Capital I at €100 million ($117.9 million). Hadean will invest €6-€8 million ($7.1-$9.4 million) in about 10-12 European start-ups, with an emphasis on the Nordic region,...
08:00 , Nov 4, 2013 |  BC Week In Review  |  Company News

Argentum Medical LLC, U.S. Department of Health and Human Services dermatology news

HHS's Biomedical Advanced Research and Development Authority (BARDA) awarded Argentum a contract to develop its Silverlon burn and wound trauma dressings for mass casualty incidents involving radiation or vesicant exposure. The contract includes a two-year...
08:00 , Feb 9, 2009 |  BioCentury  |  Finance

Ebb & Flow

Novartis (NYSE:NVS; SWX:NOVN) caused some stir last week when it unveiled plans for a $5 billion bond issue that the company said will be used "for general corporate purposes outside of Switzerland." With Pfizer (NYSE:PFE)...
08:00 , Jan 10, 2005 |  BioCentury  |  Finance

Ebb & Flow

Last week saw two series D rounds go in opposite directions. Cancer play Nereus opted for a two-part financing, and maintains that having milestone-contingent money is important for discipline. On the flip side, drug delivery...
08:00 , Jan 4, 2005 |  BC Extra  |  Financial News

First closing for NeoMed fund

NeoMed Management (Oslo, Norway) closed its fourth fund, NeoMed Innovation IV LP, at EUR 38 million ($51.6 million). The fund will invest in emerging healthcare and life sciences companies in the EU, Scandinavia, and to...